
Redentor M. Pasia
Examiner (ID: 16815, Phone: (571)272-9745 , Office: P/2479 )
| Most Active Art Unit | 2413 |
| Art Unit(s) | 2616, 2413, 2474, 2479, 2416 |
| Total Applications | 771 |
| Issued Applications | 563 |
| Pending Applications | 74 |
| Abandoned Applications | 158 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8265774
[patent_doc_number] => 20120165208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => ' METHOD FOR PREDICTING THE RESPONSIVENESS OF A PATIENT TO A TREATMENT WITH AN ANTI-CD20 ANTIBODY AND A METHOD FOR DIAGNOSING RHEUMATOID ARTHRITIS'
[patent_app_type] => utility
[patent_app_number] => 13/320054
[patent_app_country] => US
[patent_app_date] => 2010-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7529
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320054
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/320054 | METHOD FOR PREDICTING THE RESPONSIVENESS OF A PATIENT TO A TREATMENT WITH AN ANTI-CD20 ANTIBODY AND A METHOD FOR DIAGNOSING RHEUMATOID ARTHRITIS | May 17, 2010 | Abandoned |
Array
(
[id] => 8221678
[patent_doc_number] => 20120135882
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-31
[patent_title] => 'METHODS FOR DIAGNOSING CHRONIC KIDNEY DISEASE AND ASSESSING THE RISK OF DISEASE PROGRESSION'
[patent_app_type] => utility
[patent_app_number] => 13/320485
[patent_app_country] => US
[patent_app_date] => 2010-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13839
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320485
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/320485 | METHODS FOR DIAGNOSING CHRONIC KIDNEY DISEASE AND ASSESSING THE RISK OF DISEASE PROGRESSION | May 12, 2010 | Abandoned |
Array
(
[id] => 6530292
[patent_doc_number] => 20100221230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Elective Collection and Banking of Autologous Peripheral Blood Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 12/775606
[patent_app_country] => US
[patent_app_date] => 2010-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8448
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221230.pdf
[firstpage_image] =>[orig_patent_app_number] => 12775606
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/775606 | Elective Collection and Banking of Autologous Peripheral Blood Stem Cells | May 6, 2010 | Abandoned |
Array
(
[id] => 7791527
[patent_doc_number] => 20120053083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'HEPATOCELLULAR CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 13/318789
[patent_app_country] => US
[patent_app_date] => 2010-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 18242
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20120053083.pdf
[firstpage_image] =>[orig_patent_app_number] => 13318789
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/318789 | HEPATOCELLULAR CARCINOMA | May 4, 2010 | Abandoned |
Array
(
[id] => 6589757
[patent_doc_number] => 20100291647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'Microorganisms Having Enhanced Resistance To Acetate And Related Compositions And Methods of Use'
[patent_app_type] => utility
[patent_app_number] => 12/770025
[patent_app_country] => US
[patent_app_date] => 2010-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 12127
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291647.pdf
[firstpage_image] =>[orig_patent_app_number] => 12770025
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/770025 | Microorganisms Having Enhanced Resistance To Acetate And Related Compositions And Methods of Use | Apr 28, 2010 | Abandoned |
Array
(
[id] => 6631967
[patent_doc_number] => 20100311811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'RNA-MEDIATED EPIGENETIC REGULATION OF GENE TRANSCRIPTION'
[patent_app_type] => utility
[patent_app_number] => 12/769434
[patent_app_country] => US
[patent_app_date] => 2010-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 40660
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311811.pdf
[firstpage_image] =>[orig_patent_app_number] => 12769434
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/769434 | RNA-MEDIATED EPIGENETIC REGULATION OF GENE TRANSCRIPTION | Apr 27, 2010 | Abandoned |
Array
(
[id] => 6235384
[patent_doc_number] => 20100267088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'INHA PROMOTERS'
[patent_app_type] => utility
[patent_app_number] => 12/760827
[patent_app_country] => US
[patent_app_date] => 2010-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11330
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267088.pdf
[firstpage_image] =>[orig_patent_app_number] => 12760827
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/760827 | INHA PROMOTERS | Apr 14, 2010 | Abandoned |
Array
(
[id] => 6235389
[patent_doc_number] => 20100267093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'ENHANCED HOMOLOGOUS RECOMBINATION MEDIATED BY LAMBDA RECOMBINATION PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 12/760461
[patent_app_country] => US
[patent_app_date] => 2010-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 40089
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267093.pdf
[firstpage_image] =>[orig_patent_app_number] => 12760461
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/760461 | ENHANCED HOMOLOGOUS RECOMBINATION MEDIATED BY LAMBDA RECOMBINATION PROTEINS | Apr 13, 2010 | Abandoned |
Array
(
[id] => 7731629
[patent_doc_number] => 20120014987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'DNA VACCINE FOR ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/257713
[patent_app_country] => US
[patent_app_date] => 2010-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 13130
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0014/20120014987.pdf
[firstpage_image] =>[orig_patent_app_number] => 13257713
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/257713 | DNA VACCINE FOR ALZHEIMER'S DISEASE | Mar 25, 2010 | Abandoned |
Array
(
[id] => 6294976
[patent_doc_number] => 20100240133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'Compositions and Methods for Transposon Mutagenesis of Human Embryonic Stem Cells'
[patent_app_type] => utility
[patent_app_number] => 12/728943
[patent_app_country] => US
[patent_app_date] => 2010-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 21665
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240133.pdf
[firstpage_image] =>[orig_patent_app_number] => 12728943
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/728943 | Enhanced PiggyBac transposon and methods for transposon mutagenesis | Mar 21, 2010 | Issued |
Array
(
[id] => 7711751
[patent_doc_number] => 20120004136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-05
[patent_title] => 'MSH2 AND ADJUVANT CISPLATIN-BASED CHEMOTHERAPY IN NON-SMALL-CELL LUNG CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/256814
[patent_app_country] => US
[patent_app_date] => 2010-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 7796
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13256814
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/256814 | MSH2 AND ADJUVANT CISPLATIN-BASED CHEMOTHERAPY IN NON-SMALL-CELL LUNG CANCER | Mar 18, 2010 | Abandoned |
Array
(
[id] => 7778155
[patent_doc_number] => 20120040855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'TISSUE-SPECIFIC AGING BIOMARKERS'
[patent_app_type] => utility
[patent_app_number] => 13/138523
[patent_app_country] => US
[patent_app_date] => 2010-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20421
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 39
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0040/20120040855.pdf
[firstpage_image] =>[orig_patent_app_number] => 13138523
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/138523 | TISSUE-SPECIFIC AGING BIOMARKERS | Mar 9, 2010 | Abandoned |
Array
(
[id] => 6264811
[patent_doc_number] => 20100297642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-25
[patent_title] => 'METHOD FOR DETERMINING FRAMESHIFT MUTATIONS IN CODING NUCLEIC ACIDS'
[patent_app_type] => utility
[patent_app_number] => 12/714835
[patent_app_country] => US
[patent_app_date] => 2010-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 6720
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0297/20100297642.pdf
[firstpage_image] =>[orig_patent_app_number] => 12714835
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/714835 | Method for determining frameshift mutations in coding nucleic acids | Feb 28, 2010 | Issued |
Array
(
[id] => 7791520
[patent_doc_number] => 20120053076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'METHODS FOR IDENTIFICATION'
[patent_app_type] => utility
[patent_app_number] => 13/203661
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 27075
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20120053076.pdf
[firstpage_image] =>[orig_patent_app_number] => 13203661
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/203661 | METHODS FOR IDENTIFICATION | Feb 25, 2010 | Abandoned |
Array
(
[id] => 6538235
[patent_doc_number] => 20100221731
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Methods for assessing MetAP2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/711068
[patent_app_country] => US
[patent_app_date] => 2010-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 27718
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221731.pdf
[firstpage_image] =>[orig_patent_app_number] => 12711068
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/711068 | Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer as related to MetAP2 expression | Feb 22, 2010 | Issued |
Array
(
[id] => 6538203
[patent_doc_number] => 20100221729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Methods for assessing Calpain 2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/711036
[patent_app_country] => US
[patent_app_date] => 2010-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 27696
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221729.pdf
[firstpage_image] =>[orig_patent_app_number] => 12711036
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/711036 | Methods for assessing Calpain 2 Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer | Feb 22, 2010 | Abandoned |
Array
(
[id] => 6538218
[patent_doc_number] => 20100221730
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer'
[patent_app_type] => utility
[patent_app_number] => 12/711056
[patent_app_country] => US
[patent_app_date] => 2010-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 60
[patent_no_of_words] => 27698
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221730.pdf
[firstpage_image] =>[orig_patent_app_number] => 12711056
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/711056 | Methods for assessing SPARC Resistance, Disease Progression, and Treatment Efficacy in Ovarian Cancer | Feb 22, 2010 | Abandoned |
Array
(
[id] => 8313541
[patent_doc_number] => 20120190565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'Method Of Diagnosis Or Prognosis Of A Neoplasm Comprising Determining The Level Of Expression Of A Protein In Stromal Cells Adjacent To The Neoplasm'
[patent_app_type] => utility
[patent_app_number] => 13/202312
[patent_app_country] => US
[patent_app_date] => 2010-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 43125
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202312
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/202312 | Method Of Diagnosis Or Prognosis Of A Neoplasm Comprising Determining The Level Of Expression Of A Protein In Stromal Cells Adjacent To The Neoplasm | Feb 17, 2010 | Abandoned |
Array
(
[id] => 7807947
[patent_doc_number] => 20120058901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-08
[patent_title] => 'ASSAY FOR THE DETECTION OF RECURRENCE IN BREAST CANCER USING THE NOVEL TUMOR SUPPRESSOR DEAR1'
[patent_app_type] => utility
[patent_app_number] => 13/201296
[patent_app_country] => US
[patent_app_date] => 2010-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 27216
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20120058901.pdf
[firstpage_image] =>[orig_patent_app_number] => 13201296
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201296 | ASSAY FOR THE DETECTION OF RECURRENCE IN BREAST CANCER USING THE NOVEL TUMOR SUPPRESSOR DEAR1 | Feb 11, 2010 | Abandoned |
Array
(
[id] => 6149204
[patent_doc_number] => 20110020799
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'Screening method for damaged DNA repairing substance'
[patent_app_type] => utility
[patent_app_number] => 12/656408
[patent_app_country] => US
[patent_app_date] => 2010-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 9743
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0020/20110020799.pdf
[firstpage_image] =>[orig_patent_app_number] => 12656408
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/656408 | Screening method for damaged DNA repairing substance | Jan 27, 2010 | Abandoned |